FRISCO, Texas, July 17, 2017 -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that Joseph W. Dziedzic has been appointed by Integer’s Board of Directors to serve as President & Chief Executive Officer, removing his interim designation. Mr. Dziedzic has entered into a new three-year Employment Agreement with the Company effective today.
Mr. Dziedzic has served as Integer’s Interim President & CEO since March 2017 and as a director of the Company since February 2013. Previously he was Executive Vice President and Chief Financial Officer for The Brink’s Company from 2009 to 2016. Prior to that, he had a 20-year career with General Electric, in which he held leadership roles in six businesses, including General Electric Medical Systems.
Bill R. Sanford, Integer Chairman of the Board, commented, “After conducting a comprehensive search for a permanent President & CEO, the choice was clear. Joe’s deep understanding of our business, stemming from his service on the Board since 2013, coupled with his prior executive experience and the skillful leadership he demonstrated during his service as our Interim CEO, have shown him to be an ideal fit. The Board is confident Joe is the right person to lead Integer to realize our vision of enhancing the lives of patients worldwide by being our customers’ partner of choice for innovative medical technologies and services.”
“This is an exciting time for Integer,” Mr. Dziedzic stated. “As the market leader in MDO manufacturing, we have unrivaled capabilities to serve our customers’ needs across the full range of our product continuum, from medical device components to full-system solutions and devices. During my time as Interim CEO, I observed first-hand the talent, expertise and dedication of the Integer team, making me even more confident in our ability to accelerate our positive trajectory. I’m honored to lead Integer as we execute our strategy of delivering innovative, cost-effective solutions to our Customers while generating profitable growth for our Company.”
About IntegerTM
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include GreatbatchTM Medical, Lake Region MedicalTM and ElectrochemTM. Additional information is available at www.integer.net.
Investor Relations: Amy Wakeham [email protected] 214.618.4978 Media Relations: Kelly Butler [email protected] 214.618.4216


Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 



